IDT IDT Australia Limited
Healthcare · Drug Manufacturers - Specialty & Generic
· website
$0.04
52wk 0.03 – 0.09
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About IDT Australia Limited
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$16.24M
P/E (trailing)
—
P/E (forward)
3.80
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
0.90
EV / EBITDA
-5.17
Price / Book
0.79
ROE
-26.1%
Operating margin
-9.1%
Net margin
-32.3%
Total cash
$4.03M
Total debt
$9.86M
Current ratio
2.97
Debt / Equity
0.49
Free cash flow
$-26,500
Avg volume
237,834
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$19.22M
- Gross profit$13.10M
- Operating income-$7.95M
- Net income-$8.06M
- Diluted EPS-0.02
- Free cash flow-$7.55M
- Net debt$9.90M